Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cristina Pellegrino Baena is active.

Publication


Featured researches published by Cristina Pellegrino Baena.


BMJ | 2014

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies

Rajiv Chowdhury; Setor K. Kunutsor; Anna Vitezova; Clare Oliver-Williams; Susmita Chowdhury; Jessica C Kiefte-de-Jong; Hassan Khan; Cristina Pellegrino Baena; Dorairaj Prabhakaran; Moshe Hoshen; Becca S. Feldman; An Pan; Laura Johnson; Francesca L. Crowe; Frank B. Hu; Oscar H. Franco

Objective To evaluate the extent to which circulating biomarker and supplements of vitamin D are associated with mortality from cardiovascular, cancer, or other conditions, under various circumstances. Design Systematic review and meta-analysis of observational studies and randomised controlled trials. Data sources Medline, Embase, Cochrane Library, and reference lists of relevant studies to August 2013; correspondance with investigators. Study selection Observational cohort studies and randomised controlled trials in adults, which reported associations between vitamin D (measured as circulating 25-hydroxyvitamin D concentration or vitamin D supplement given singly) and cause specific mortality outcomes. Data extraction Data were extracted by two independent investigators, and a consensus was reached with involvement of a third. Study specific relative risks from 73 cohort studies (849 412 participants) and 22 randomised controlled trials (vitamin D given alone versus placebo or no treatment; 30 716 participants) were meta-analysed using random effects models and were grouped by study and population characteristics. Results In the primary prevention observational studies, comparing bottom versus top thirds of baseline circulating 25-hydroxyvitamin D distribution, pooled relative risks were 1.35 (95% confidence interval 1.13 to 1.61) for death from cardiovascular disease, 1.14 (1.01 to 1.29) for death from cancer, 1.30 (1.07 to 1.59) for non-vascular, non-cancer death, and 1.35 (1.22 to 1.49) for all cause mortality. Subgroup analyses in the observational studies indicated that risk of mortality was significantly higher in studies with lower baseline use of vitamin D supplements. In randomised controlled trials, relative risks for all cause mortality were 0.89 (0.80 to 0.99) for vitamin D3 supplementation and 1.04 (0.97 to 1.11) for vitamin D2 supplementation. The effects observed for vitamin D3 supplementation remained unchanged when grouped by various characteristics. However, for vitamin D2 supplementation, increased risks of mortality were observed in studies with lower intervention doses and shorter average intervention periods. Conclusions Evidence from observational studies indicates inverse associations of circulating 25-hydroxyvitamin D with risks of death due to cardiovascular disease, cancer, and other causes. Supplementation with vitamin D3 significantly reduces overall mortality among older adults; however, before any widespread supplementation, further investigations will be required to establish the optimal dose and duration and whether vitamin D3 and D2 have different effects on mortality risk.


European Journal of Preventive Cardiology | 2015

Mind–body practices for patients with cardiac disease: a systematic review and meta-analysis

John O. Younge; Rinske A. Gotink; Cristina Pellegrino Baena; Jolien W. Roos-Hesselink; M. G. Myriam Hunink

Background Due to new treatment modalities in the last decades, a decline in cardiovascular deaths has been observed. There is an emerging field of secondary prevention and behavioural programmes with increased interest in the use of mind–body practices. Until now, these have not been established in cardiovascular disease treatment programmes. Design We performed a systematic review and meta-analysis of the available evidence on the effectiveness of mind–body practices for patients with diagnosed cardiac disease. Methods We included randomized controlled trials (RCTs), published in English, reporting mind–body practices for patients with diagnosed cardiac disease. EMBASE, MEDLINE, Pubmed, Web of Science, The Cochrane Central Register of Controlled Trials and PsycINFO were searched up to July 2013. Two reviewers independently identified studies for inclusion and extracted data on study characteristics, outcomes (Quality of Life, anxiety, depression, physical parameters and exercise tolerance) and quality assessment. Standardized effect sizes (Cohen’s d) were calculated comparing the outcomes between the intervention and control group and random effects meta-analysis was conducted. Results We identified 11 unique RCTs with an overall low quality. The studies evaluated mindfulness-based stress reduction, transcendental meditation, progressive muscle relaxation and stress management. Pooled analyses revealed effect sizes of 0.45 (95%CI 0.20–0.72) for physical quality of life, 0.68 (95%CI 0.10–1.26) for mental quality of life, 0.61 (95%CI 0.23–0.99) for depression, 0.52 (95%CI 0.26–0.78) for anxiety, 0.48 (95%CI 0.27–0.69) for systolic blood pressure and 0.36 (95%CI 0.15–0.57) for diastolic blood pressure. Conclusions Mind–body practices have encouraging results for patients with cardiac disease. Our review demonstrates the need for high-quality studies in this field.


The American Journal of Clinical Nutrition | 2016

The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis

Elisabeth T.M. Leermakers; Sirwan K.L. Darweesh; Cristina Pellegrino Baena; Eduardo M. Moreira; Debora Melo van Lent; Myrte J. Tielemans; Taulant Muka; Anna Vitezova; Rajiv Chowdhury; Wichor M. Bramer; Jessica C. Kiefte-de Jong; Janine F. Felix; Oscar H. Franco

BACKGROUND The antioxidant lutein is suggested as being beneficial to cardiometabolic health because of its protective effect against oxidative stress, but evidence has not systematically been evaluated. OBJECTIVE We aimed to evaluate systematically the effects of lutein (intake or concentrations) on cardiometabolic outcomes in different life stages. DESIGN This is a systematic review with meta-analysis of literature published in MEDLINE, Embase, Cochrane Central, Web of Science, PubMed, and Google Scholar up to August 2014. Included were trials and cohort, case-control, and cross-sectional studies in which the association between lutein concentrations, dietary intake, or supplements and cardiometabolic outcomes was reported. Two independent investigators reviewed the articles. RESULTS Seventy-one relevant articles were identified that included a total of 387,569 participants. Only 1 article investigated the effects of lutein during pregnancy, and 3 studied lutein in children. Furthermore, 31 longitudinal, 33 cross-sectional, and 3 intervention studies were conducted in adults. Meta-analysis showed a lower risk of coronary heart disease (pooled RR: 0.88; 95% CI: 0.80, 0.98) and stroke (pooled RR: 0.82; 95% CI: 0.72, 0.93) for the highest compared with the lowest tertile of lutein blood concentration or intake. There was no significant association with type 2 diabetes mellitus (pooled RR: 0.97; 95% CI: 0.77, 1.22), but higher lutein was associated with a lower risk of metabolic syndrome (pooled RR: 0.75; 95% CI: 0.60, 0.92) for the highest compared with the lowest tertile. The literature on risk factors for cardiometabolic diseases showed that lutein might be beneficial for atherosclerosis and inflammatory markers, but there were inconsistent associations with blood pressure, adiposity, insulin resistance, and blood lipids. CONCLUSIONS Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health. However, evidence mainly comes from observational studies in adults, whereas large-scale intervention studies and studies of lutein during pregnancy and childhood are scarce.


Heart | 2013

Ischaemic heart disease deaths in Brazil: current trends, regional disparities and future projections

Cristina Pellegrino Baena; Rajiv Chowdhury; Nicolle Amboni Schio; Ary Elias Sabbag; Luiz César Guarita-Souza; Marcia Olandoski; Oscar H. Franco; José Rocha Faria-Neto

Objective To quantify the trend of ischaemic heart disease (IHD) deaths in Brazil during the last decade (2000–2010) for various population characteristics and to forecast the upcoming mortality trends across regions in Brazil until the year 2015. Design Nationwide comparative observational study. Patients and methods The population studied encompassed all adult residents (≥20 years) living in five Brazilian regions between 2000 and 2010. Demographic, economic and mortality data were obtained from Brazilian National Mortality Data System and National Applied Economics Research Institute. Subnotified deaths were redistributed proportionally to IHD deaths. Age-standardised mortality rates (ASMRs) per 100 000 inhabitants, by sex and region, were calculated employing a standard Brazilian population and constructing multivariate regression models to quantify and to project temporal trends. Main outcome measures Absolute numbers of death due to IHD and region-specific death rates in Brazil by age and sex. Results During the study period, 627 786 men and 452 690 women died due to IHD in Brazil. ASMR trends across all regions for men and women converged, driven by a declining trend in the South and Southeast and an opposite incline in the North and Northeast (p<0.05). Future projections demonstrated potential widening of the observed North–South gap in coming years. Conclusions The IHD death trend in Brazil has changed from a decline to a stagnant state. However, a significant discrepancy in mortality trends exists between the northern and southern regions, which is likely to widen further. Reappraisal of the public health policies tailored to populations with diverse socioeconomic structures is urgently required.


Journal of Hypertension | 2014

Effects of lifestyle-related interventions on blood pressure in low and middle-income countries: systematic review and meta-analysis.

Cristina Pellegrino Baena; Marcia Olandoski; John O. Younge; Adriana Buitrago-Lopez; Sirwan K.L. Darweesh; Natalia Campos; Sanaz Sedaghat; Ayesha Sajjad; Thijs T.W. van Herpt; Rosanne Freak-Poli; Edith van den Hooven; Janine F. Felix; José Rocha Faria-Neto; Rajiv Chowdhury; Oscar H. Franco

Despite the overwhelming evidence supporting the effectiveness of antihypertensive medication, hypertension remains poorly controlled in low and middle-income countries (LMICs). Lifestyle intervention studies reporting effects on blood pressure published from January 1977 to September 2012 were searched on various databases. From the 6211 references identified, 52 were included in the systematic review (12 024 participants) and 43 were included in the meta-analysis (in total 6779 participants). We calculated and pooled effect sizes in mmHg with random-effects models. We grouped interventions into behavioral counseling (1831 participants), dietary modification (1831 participants), physical activity (1014 participants) and multiple interventions (2103 participants). Subgroup analysis and meta-regression were used to evaluate origins of heterogeneity. Lifestyle interventions significantly lowered blood pressure levels in LMIC populations, including in total 6779 participants. The changes achieved in SBP (95% confidence interval) were: behavioral counseling −5.4 (−10.7, −0.0) mmHg, for dietary modification −3.5 (−5.4, −1.5) mmHg, for physical activity −11.4 (−16.0, −6.7) mmHg and for multiple interventions −6.0 (−8.9, −3.3) mmHg. The heterogeneity was high across studies and the quality was generally low. Subgroup analyses showed smaller samples reporting larger effect sizes; intervention lasting less than 6 months showed larger effect sizes and intention-to-treat analysis showed smaller effect sizes Lifestyle interventions may be of value in preventing and reducing blood pressure in LMICs. Nevertheless, the overall quality and sample size of the studies included were low. Improvements in the size and quality of studies evaluating lifestyle interventions are required.


Einstein (São Paulo) | 2013

Efeitos de curto prazo de um programa de atividade física moderada em pacientes com síndrome metabólica

Caroline Macoris Colombo; Rafael Michel de Macedo; Miguel Morita Fernandes-Silva; Alexandra Moro Caporal; Andréa E. M. Stinghen; Costantino R. Costantini; Cristina Pellegrino Baena; Luiz César Guarita-Souza; José Rocha Faria-Neto

ABSTRACT Objectives: To evaluate whether a short-term moderate intensity exercise program could change inflammatory parameters, and improve different components of metabolic syndrome in sedentary patients. Methods: Sixteen patients completed the 12-week program of supervised exercise, which consisted of a 40 to 50 minutes of walking, 3 times a week, reaching 50 to 60% of the heart rate reserve. The parameters evaluated before and after intervention were waist circumference, systolic and diastolic blood pressure, triglycerides, LDL cholesterol, HDL cholesterol, total cholesterol, C-reactive protein and interleukin 8. Results: There was a significant reduction in waist circumference (102.1±7.5cm to 100.8±7.4cm; p=0.03) and in body mass index (29.7±3.2kg/m2 versus 29.3±3.5kg/m2; p=0.03). Systolic blood pressure dropped from 141±18 to 129±13mmHg and diastolic from 79±12 to 71±10mmHg (with p<0.05 for both). No changes were observed on total cholesterol, LDL cholesterol and triglycerides, although HDL cholesterol levels improved, from 45.5±6.0 to 49.5±9.8mg/dL (p=0.02). There was a trend toward reduction of C-reactive protein (8.3%; p=0.07) and interleukin 8 levels (17.4%; p=0.058). The improvement in cardiovascular capacity was demonstrated by an increase of 13% in estimated volume of oxygen (p<0.001). Conclusion: Benefits of aerobic exercise of moderate intensity were seen within only 12 weeks of training in sedentary patients with metabolic syndrome. Considering the easy self-applicability and proven metabolic effects, an exercise program could be a first approach to sedentary patients with metabolic syndrome.


Journal of The Peripheral Nervous System | 2014

Health‐related quality of life in Guillain‐Barré syndrome patients: a systematic review

Sirwan K.L. Darweesh; Suzanne Polinder; Maxim J.H.L. Mulder; Cristina Pellegrino Baena; Nikki van Leeuwen; Oscar H. Franco; Bart C. Jacobs; Pieter A. van Doorn

Guillain‐Barré syndrome (GBS) encompasses a broad spectrum of health‐related quality of life (HRQL) determinants, including mobility, fatigue, pain, and depression. We systematically reviewed the literature on functional outcome domains in which GBS patients experience limitations in the short and long terms and evaluated determinants of HRQL in GBS patients. MEDLINE and EMBASE were systematically searched by two independent reviewers for articles covering HRQL data of GBS patients. Of 730 abstracts screened, 17 articles covering data of 14 studies matched the selection criteria. The included articles showed that many GBS patients experienced physical limitations, even years after the acute phase of the disease, while results were inconsistent for perceived levels of pain, fatigue, and general mental well‐being. Only three papers covered HRQL assessments at more than one time point, generally showing large improvements in HRQL in the first year after GBS onset, but not thereafter. We appraised the methodological quality of included studies using a 13‐item checklist; none of the articles fulfilled all items and only seven articles presented data on correlations between HRQL and determinants. In conclusion, the majority of studies on HRQL in GBS patients are cross‐sectional and of low methodological quality. This paper provides guidance for much needed high‐quality studies on patterns of patient‐perceived recovery after GBS onset.


Revista De Saude Publica | 2016

ERICA: prevalence of dyslipidemia in Brazilian adolescents

José Rocha Faria Neto; Vivian Freitas Rezende Bento; Cristina Pellegrino Baena; Marcia Olandoski; Luis Gonzaga de Oliveira Gonçalves; Gabriela de Azevedo Abreu; Maria Cristina Caetano Kuschnir; Katia Vergetti Bloch

ABSTRACT OBJECTIVE To determine the distribution of total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides in Brazilian adolescents, as well as the prevalence of altered levels of such parameters. METHODS Data from the Study of Cardiovascular Risks in Adolescents (ERICA) were used. This is a country-wide, school-based cross-sectional study that evaluated 12 to 17-year old adolescents living in cities with over 100,000 inhabitants. The average and distribution of plasma levels of total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides were evaluated. Dyslipidemia was determined by levels of total cholesterol ≥ 170 mg/dl, LDL cholesterol ≥ 130 mg/dl, HDL cholesterol < 45 mg/dL, or triglycerides ≥ 130 mg/dl. The data were analyzed by gender, age, and regions in Brazil. RESULTS We evaluated 38,069 adolescents – 59.9% of females, and 54.2% between 15 and 17 years. The average values found were: total cholesterol = 148.1 mg/dl (95%CI 147.1-149.1), HDL cholesterol = 47.3 mg/dl (95%CI 46.7-47.9), LDL cholesterol = 85.3 mg/dl (95%CI 84.5-86.1), and triglycerides = 77.8 mg/dl (95%CI 76.5-79.2). The female adolescents had higher average levels of total cholesterol, LDL cholesterol, and HDL cholesterol, without differences in the levels of triglycerides. We did not observe any significant differences between the average values among 12 to 14 and 15- to 17-year old adolescents. The most prevalent lipid alterations were low HDL cholesterol (46.8% [95%CI 44.8-48.9]), hypercholesterolemia (20.1% [95%CI 19.0-21.3]), and hypertriglyceridemia (7.8% [95%CI 7.1-8.6]). High LDL cholesterol was found in 3.5% (95%CI 3.2-4.0) of the adolescents. Prevalence of low HDL cholesterol was higher in Brazil’s North and Northeast regions. CONCLUSIONS A significant proportion of Brazilian adolescents has alterations in their plasma lipids. The high prevalence of low HDL cholesterol and hypertriglyceridemia, especially in Brazil’s North and Northeast regions, must be analyzed in future studies, to support the creation of strategies for efficient interventions.


Nutrition Metabolism and Cardiovascular Diseases | 2016

Neck circumference is associated with carotid intimal-media thickness but not with coronary artery calcium: Results from The ELSA-Brasil

Cristina Pellegrino Baena; Paulo A. Lotufo; Itamar S. Santos; Alessandra C. Goulart; Marcio Sommer Bittencourt; Bruce Bartholow Duncan; Simin Liu; Isabela M. Benseñor

BACKGROUND AND AIMS It is uncertain whether neck circumference can be a risk indicator for subclinical atherosclerosis. We aimed to investigate their relationships measured by coronary artery calcium (CAC) and common carotid intima-media thickness (cc-IMT) with neck circumference in ELSA-Brasil. METHODS AND RESULTS In cross-sectional and sex-specific analyses of 2266 women (50.6 ± 8.4 yrs) and 1886 men (50.7 ± 9.0 yrs) with both cc-IMT and CAC, free from previous cardiovascular disease at baseline, we built logistic models using diverse cut-off points for CAC score (0 vs > 0, < 100 vs ≥ 100, < 400 vs ≥ 400 Agatston units) and cc-IMT (< 75 th percentile vs ≥ 75 th; <90th percentile vs ≥ 90 th) as dependent variables, after which adjustments for age and traditional cardiovascular risk factors were made. Mean neck circumference was 33.6 (± 2.4 cm) for women and 38.8 (± 2.6 cm) for men. In fully adjusted models including sociodemographic, cardiovascular risk factors and body-mass index and waist circumference, for each 1 standard deviation increase in neck circumference we found an odds ratio (OR, 95% CI) for IMT above the 75th percentile of (1.52, 1.16; 1.99) for women and (1.66, 1.28; 2.14) for men, and above the 90th cc-IMT percentile [1.66 (1.19; 2.32) for men but not for women [1.21 (0.80; 1.82)]. We found no association between neck circumference and CAC using different cut-off points (p > 0.05 for all). CONCLUSION Neck circumference was significantly and independently associated with cc-IMT but not with CAC in women and men, indicating a possible effect of perivascular fat tissue on atherosclerosis.


Revista De Saude Publica | 2016

ERICA: prevalência de dislipidemia em adolescentes brasileiros

José Rocha Faria Neto; Vivian Freitas Rezende Bento; Cristina Pellegrino Baena; Marcia Olandoski; Luis Gonzaga de Oliveira Gonçalves; Gabriela de Azevedo Abreu; Maria Cristina Caetano Kuschnir; Katia Vergetti Bloch

OBJETIVO Determinar a distribuicao de colesterol total, LDL-colesterol, HDL-colesterol e triglicerideos em adolescentes brasileiros, bem como a prevalencia de niveis alterados de tais parâmetros. METODOS Foram utilizados dados do Estudo de Riscos Cardiovasculares em Adolescentes (ERICA), estudo transversal, de âmbito nacional e base escolar que avaliou adolescentes de 12 a 17 anos, residentes em municipios com mais de 100 mil habitantes. Foi avaliada a media e distribuicao dos niveis plasmaticos de colesterol total, LDL-colesterol, HDL-colesterol e triglicerideos. Dislipidemia foi determinada por niveis de colesterol total ≥ 170 mg/dl, LDL-colesterol ≥ 130 mg/dl, HDL-colesterol < 45 mg/dL ou triglicerideos ≥ 130 mg/dl. Os dados foram analisados por sexo, idade e regioes do Brasil. RESULTADOS Foram avaliados 38.069 adolescentes, 59,9% do sexo feminino; 54,2% com idade entre 15 a 17 anos. Os valores medios encontrados foram: colesterol total 148,1 mg/dl (IC95% 147,1-149,1), HDL-colesterol 47,3 mg/dl (IC95% 46,7-47,9), LDL-colesterol 85,3 mg/dl (IC95% 84,5-86,1), e triglicerideos 77,8 mg/dl (IC95% 76,5-79,2). Adolescentes do sexo feminino apresentaram niveis medios de colesterol total, LDL-colesterol e HDL-colesterol mais elevados, mas sem diferenca nos niveis de triglicerideos. Nao houve diferenca significativa de valores medios entre adolescentes de 12 a 14 e de 15 a 17 anos. As alteracoes com maior prevalencia foram HDL-colesterol baixo (46,8% [IC95% 44,8-48,9]), hipercolesterolemia (20,1% [IC95% 19,0-21,3]) e hipertrigliceridemia (7,8% [IC95% 7,1-8,6]). O LDL-colesterol elevado foi observado em 3,5% (IC95% 3,2-4,0) dos adolescentes. As prevalencias de HDL-colesterol baixo foram mais elevadas nas regioes Norte e Nordeste do Pais. CONCLUSOES Uma parcela significativa dos adolescentes brasileiros apresenta alteracoes dos lipides plasmaticos. A alta prevalencia de HDL-colesterol baixo e a hipertrigliceridemia, sobretudo nas regioes Norte e Nordeste do Brasil, devem ser analisadas em futuros estudos para subsidiar formulacoes de estrategias de intervencoes eficazes.

Collaboration


Dive into the Cristina Pellegrino Baena's collaboration.

Top Co-Authors

Avatar

José Rocha Faria-Neto

Pontifícia Universidade Católica do Paraná

View shared research outputs
Top Co-Authors

Avatar

Luiz César Guarita-Souza

Pontifícia Universidade Católica do Paraná

View shared research outputs
Top Co-Authors

Avatar

Marcia Olandoski

Pontifícia Universidade Católica do Paraná

View shared research outputs
Top Co-Authors

Avatar

Oscar H. Franco

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Julio Cesar Francisco

Pontifícia Universidade Católica do Paraná

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rafael Michel de Macedo

Pontifícia Universidade Católica do Paraná

View shared research outputs
Top Co-Authors

Avatar

José Rocha Faria Neto

Pontifícia Universidade Católica do Paraná

View shared research outputs
Top Co-Authors

Avatar

Vivian Ferreira do Amaral

Pontifícia Universidade Católica do Paraná

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge